MedPath

Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or Occlusion

Not Applicable
Completed
Conditions
Iliac Vein Occlusion
Iliac Vein Stenosis
Registration Number
NCT04812444
Lead Sponsor
Zhejiang Zylox Medical Device Co., Ltd.
Brief Summary

Clinical study on safety and efficacy of Zylox peripheral venous stent system in the treatment of iliac vein stenosis or occlusion.

Detailed Description

The purpose of this study was to evaluate the safety and efficacy of Zylox peripheral venous stent system in the treatment of iliac vein stenosis or occlusive lesions compare with conventional venous stent.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
220
Inclusion Criteria
  • Aged from 18 to 75 years old, male or female
  • Subject's target lesions were stenosis and/or occlusion
  • CEAP≥C3
  • Subjects were able to understand the purpose of the study, demonstrate full compliance with the program and sign informed consent
Exclusion Criteria
  • Pregnant woman or who's pregnancy test is positive
  • Lactation period woman or woman/man with fertility plan

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Target vascular patency rate at 12 months after operation12 months

Target vascular patency rate

Secondary Outcome Measures
NameTimeMethod
Adverse EventPreoperative、Intraoperative、up to 1 month、3 month、6 month、12 month、2 years、3 years、5 years

Adverse medical events,whether or not related to the medical device

The incidence of major adverse events12 months

Related to death of clinical trials

Trial Locations

Locations (1)

The First Affiliated Hospital of Chongqing Medical University

🇨🇳

Chongqing, Chongqing, China

The First Affiliated Hospital of Chongqing Medical University
🇨🇳Chongqing, Chongqing, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.